Neoadjuvant Cytoreductive Treatment With BRAF / MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial

  • Stéphanie A. Blankenstein
  • , Maartje W. Rohaan
  • , Willem Martin C. Klop
  • , Bernies Van Der Hiel
  • , Bart A. Van De Wiel
  • , Max J. Lahaye
  • , Sandra Adriaansz
  • , Karolina Sikorska
  • , Harm Van Tinteren
  • , Aysegül Sari
  • , Lindsay G. Grijpink-Ongering
  • , Winan J. Van Houdt
  • , Michel W.J.M. Wouters
  • , Christian U. Blank
  • , Sofie Wilgenhof
  • , Johannes V. Van Thienen
  • , Alexander C.J. Van Akkooi
  • , John B.A.G. Haanen

Research output: Contribution to journal › Article › peer-review

38 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Neoadjuvant Cytoreductive Treatment With BRAF / MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry